Most Alzheimer’s Patients May Be Ineligible for Newly Approved Drugs
THURSDAY, Aug. 17, 2023 (HealthDay News) — Two recently approved treatments offer newfound hope for patients in the early stages of Alzheimer’s disease, but most people who could benefit will likely be deemed ineligible, a new study finds. Alzheimer’s affects about 6.7 million Americans age 65 and older. But onlyContinue Reading